Graham Corp: Form 10-Q for the period ended Dec 31, 2023
Filed with the SEC on Feb 5, 2024 and accepted by EDGAR at Feb 5, 2024, 08:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $43.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-04-01 to 2023-12-31 | $136.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-10-01 to 2023-12-31 | $34.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-04-01 to 2023-12-31 | $108.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-10-01 to 2023-12-31 | $9.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-04-01 to 2023-12-31 | $27.9m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-10-01 to 2023-12-31 | $8.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-04-01 to 2023-12-31 | $21.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-10-01 to 2023-12-31 | $911.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-04-01 to 2023-12-31 | $5.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-10-01 to 2023-12-31 | $37.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2023-04-01 to 2023-12-31 | $277.0k | us-gaap:InterestExpense |
| Income tax | 3 months2023-10-01 to 2023-12-31 | −$110.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-04-01 to 2023-12-31 | $899.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | $165.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-04-01 to 2023-12-31 | $3.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | $0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-04-01 to 2023-12-31 | $0.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | $0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-04-01 to 2023-12-31 | $0.30 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-01 to 2023-12-31 | 10,920,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-04-01 to 2023-12-31 | 10,792,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-04-01 to 2023-12-31 | $19.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-04-01 to 2023-12-31 | $5.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2023-04-01 to 2023-12-31 | $57.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $15.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $115.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $218.7m | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $103.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $115.0m | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $0 | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-12-31 | $0 | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2023-12-31 | $3.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-12-31 | $103.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-011023. Last ingested by Listed: Oct 27, 2026, 09:59 ET. Listed shows no prices and gives no investment advice.